Skip to main content
. 2020 Nov 17;4:PO.20.00273. doi: 10.1200/PO.20.00273

FIG 2.

FIG 2.

Patient flowchart. CT, computed tomography; ER+, estrogen receptor positive; FDG PET, fluorodeoxyglucose positron emission tomography; HER2-negative, human epidermal growth factor receptor negative; TNBC, triple-negative breast cancer; TTP, time to progression.